News & Updates

Treatment with the NOV03 (perfluorohexyloctane) ophthalmic drop is well tolerated and yields significant improvements in the signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction, according to the results of a phase III study.

Children born to parents with astigmatism are likely to develop refractive or corneal astigmatism, according to a study, suggesting that parental astigmatism has an independent and dose-dependent association with child astigmatism.

Frailty syndrome is an independent predictor of endogenous endophthalmitis (EE) development in the setting of bacterial septicemia, suggests a recent study. Furthermore, frailty-induced EE tends to occur in patients with malnutrition and certain bacterial subtypes and may lead to greater in-hospital death and healthcare resource usage.

Lenadogene nolparvovec is well tolerated among patients with Leber hereditary optic neuropathy, being associated with mostly mild ocular side effects that can be resolved with conventional ophthalmologic treatments, according to the results of the LHON study.

In patients with diffractive multifocal intraocular lenses (MIOL), age is associated with worse visual acuity (VA) and area-of-focus (AoF), a recent study has found.

Among children with penetrating keratoplasty, using oral tacrolimus for postoperative immunosuppression is safe, with encouraging rates of rejection-free survival and overall graft survival, a recent study has found.

A commercially available eye drop adapter device, dubbed the Nanodropper, results in comparable pupil diameter as standard of care (SOC) for routine pupillary dilation in paediatric patients, according to a recent study.